Clinical Trial Update: Effectiveness of Ketamine in Malignant Neuropathic Pain Relief [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ketamine for malignant neuropathic pain has been withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Pain, Intractable | Phase 3 | Status: WITHDRAWN